Whether age-dependent loss of TAK1 and, based on the findings of our study, presumably, a decrease of the TAK1-IKKα/β-Hsc70 signaling that would result in a decrease of CMA-mediated clearance of APP contributes to the pathogenesis of AD or other neurodegenerative diseases remains to be investigated. Here, MAP3K7 is linked to Alzheimer disease.